Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

F

FATE

Fate Therapeutics Inc

2.47

Aug 04 • 4:47 AM ET -0.03 (-1.16%)

Healthcare Biotechnology USA Micro NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: VTI VXF SCHA IWC VHT PRFZ BUSM SCHB AVSC DFMC

Scroll to Statements

Index	-
Market Cap	288.03M
Enterprise Value	189.99M
Income	-129.91M
Sales	6.32M
Book/sh	1.55
Cash/sh	1.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	45.57
P/B	1.60
P/C	1.65
P/FCF	-
EV/EBITDA	-
EV/Sales	30.06
Quick Ratio	5.85
Current Ratio	5.85
Debt/Eq	0.43
LT Debt/Eq	0.40
Option/Short	Yes / Yes

EPS (ttm)	-1.09
EPS next Y	-1.03
EPS next Q	-0.27
EPS this Y	5.93%
EPS next Y	4.70%
EPS next 5Y	2.41%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	26.97%
Sales Y/Y TTM	-52.64%
EPS Q/Q	18.19%
Sales Q/Q	-20.26%
Earnings	May 13 BMO
EPS/Sales Surpr.	7.14% -12.93%

Insider Own	5.16%
Insider Trans	-0.90%
Inst Own	60.75%
Inst Trans	3.52%
ROA	-38.01%
ROE	-55.50%
ROIC	-51.60%
Gross Margin	-97.69%
Oper. Margin	-2207.47%
Profit Margin	-2056.79%
SMA20	-8.18%
SMA50	0.56%
SMA200	56.42%
Trades

Shs Outstand	116.27M
Shs Float	110.55M
Short Float	6.62%
Short Ratio	1.80
Short Interest	7.32M
52W High	3.23 -23.50%
52W Low	0.91 171.55%
Volatility	7.66% 7.96%
ATR (14)	0.20
RSI (14)	47.08
Beta	2.55
Rel Volume	0.00
Avg Volume	4.06M
Volume	630

Perf Week	6.51%
Perf Month	-17.35%
Perf Quarter	37.28%
Perf Half Y	100.90%
Perf YTD	151.49%
Perf Year	133.12%
Perf 3Y	-33.75%
Perf 5Y	-97.12%
Perf 10Y	18.80%
Recom	2.00
Target Price	5.41
Prev Close	2.50
Price	2.47
Change	-1.16%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)